{
    "moduleId": "module_19",
    "moduleTitle": "L2: Research & Evidence",
    "passingScore": 80,
    "questions": [
        {
            "id": "q19_1",
            "question": "According to the Hierarchy of Evidence in botanical medicine, which of the following represents the highest level of clinical certainty?",
            "options": [
                "Case reports and series",
                "Expert opinion and traditional use monographs",
                "Systematic reviews and meta-analyses of RCTs",
                "In vitro (cell culture) mechanistic studies"
            ],
            "correctAnswer": 2,
            "explanation": "Systematic reviews and meta-analyses of Randomized Controlled Trials (RCTs) sit at the top of the evidence pyramid as they synthesize data from multiple high-quality studies to provide a statistical consensus."
        },
        {
            "id": "q19_2",
            "question": "When navigating databases like PubMed, which Boolean operator would a practitioner use to retrieve articles that discuss either 'Ginkgo biloba' or its synonym 'Maidenhair tree'?",
            "options": [
                "AND",
                "OR",
                "NOT",
                "NEAR"
            ],
            "correctAnswer": 1,
            "explanation": "The 'OR' operator expands a search to include results containing any of the specified terms, which is ideal for searching synonyms or related botanical names."
        },
        {
            "id": "q19_3",
            "question": "In pharmacokinetics, the 'First-Pass Effect' significantly reduces the bioavailability of certain phytochemicals. Where does this process primarily occur?",
            "options": [
                "The kidneys via glomerular filtration",
                "The liver via the portal vein after intestinal absorption",
                "The stomach via gastric acid hydrolysis",
                "The lungs via alveolar gas exchange"
            ],
            "correctAnswer": 1,
            "explanation": "The first-pass effect occurs when an orally administered substance is absorbed from the GI tract into the portal circulation and metabolized by the liver before it ever reaches systemic circulation."
        },
        {
            "id": "q19_4",
            "question": "Which term describes a pharmacodynamic interaction where a phytochemical binds to a receptor and prevents the endogenous ligand from eliciting a response?",
            "options": [
                "Agonist",
                "Antagonist",
                "Synergist",
                "Potentiator"
            ],
            "correctAnswer": 1,
            "explanation": "An antagonist binds to a receptor but does not activate it; instead, it blocks or 'antagonizes' the action of agonists or natural hormones/neurotransmitters."
        },
        {
            "id": "q19_5",
            "question": "St. John's Wort (Hypericum perforatum) is clinically significant in Herb-Drug Interactions (HDI) because it acts as a potent inducer of which enzyme?",
            "options": [
                "CYP3A4",
                "Cyclooxygenase-2 (COX-2)",
                "Acetylcholinesterase",
                "MAO-B"
            ],
            "correctAnswer": 0,
            "explanation": "St. John's Wort induces the CYP3A4 enzyme system in the liver, which accelerates the metabolism of many pharmaceuticals (like cyclosporine and warfarin), leading to sub-therapeutic drug levels."
        },
        {
            "id": "q19_6",
            "question": "A practitioner is reviewing the toxicology of Comfrey (Symphytum officinale). Which specific constituents are responsible for its known risk of hepatic veno-occlusive disease?",
            "options": [
                "Triterpene saponins",
                "Isoquinoline alkaloids",
                "Unsaturated Pyrrolizidine Alkaloids (PAs)",
                "Condensed tannins"
            ],
            "correctAnswer": 2,
            "explanation": "Unsaturated Pyrrolizidine Alkaloids (PAs) are pro-toxins that, when metabolized by the liver, create reactive metabolites that cause DNA damage and hepatotoxicity."
        },
        {
            "id": "q19_7",
            "question": "When researching herbal safety for a pediatric population, why is the 'surface area-to-weight ratio' a critical pharmacokinetic consideration?",
            "options": [
                "Children have slower heart rates than adults",
                "Children have a higher relative surface area, affecting percutaneous absorption and fluid balance",
                "Children have more acidic gastric pH than adults",
                "Children have higher levels of plasma protein binding"
            ],
            "correctAnswer": 1,
            "explanation": "Children, especially infants, have a higher surface area-to-body weight ratio, which can lead to increased absorption of topical preparations and different metabolic requirements compared to adults."
        },
        {
            "id": "q19_8",
            "question": "In the PICO clinical question framework, what does the 'I' represent?",
            "options": [
                "Investigation",
                "Intervention",
                "Indication",
                "Interaction"
            ],
            "correctAnswer": 1,
            "explanation": "PICO stands for Patient/Population, Intervention (the herb or treatment being studied), Comparison (placebo or standard care), and Outcome."
        },
        {
            "id": "q19_9",
            "question": "If a phytochemical has a half-life (tÂ½) of 6 hours, how much of the original dose remains in the patient's system after 12 hours (assuming no further doses are taken)?",
            "options": [
                "50%",
                "33%",
                "25%",
                "12.5%"
            ],
            "correctAnswer": 2,
            "explanation": "After one half-life (6 hours), 50% remains. After two half-lives (12 hours), 50% of that 50% remains, which is 25%."
        },
        {
            "id": "q19_10",
            "question": "A 2022 meta-analysis regarding Echinacea for the common cold suggested that while it may not prevent the onset of a cold, it may reduce duration by an average of how many days?",
            "options": [
                "0.5 days",
                "1.4 days",
                "3.2 days",
                "5.0 days"
            ],
            "correctAnswer": 1,
            "explanation": "Recent high-quality meta-analyses often show a modest but statistically significant reduction in duration, typically cited around 1.4 to 1.5 days when standardized extracts are used at the onset of symptoms."
        }
    ]
}